EP2032139A4 - Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone - Google Patents
Compositions comprising nanoparticulate meloxicam and controlled release hydrocodoneInfo
- Publication number
- EP2032139A4 EP2032139A4 EP07784540A EP07784540A EP2032139A4 EP 2032139 A4 EP2032139 A4 EP 2032139A4 EP 07784540 A EP07784540 A EP 07784540A EP 07784540 A EP07784540 A EP 07784540A EP 2032139 A4 EP2032139 A4 EP 2032139A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- controlled release
- release hydrocodone
- nanoparticulate meloxicam
- nanoparticulate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81588406P | 2006-06-23 | 2006-06-23 | |
PCT/US2007/072054 WO2007150075A2 (en) | 2006-06-23 | 2007-06-25 | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2032139A2 EP2032139A2 (en) | 2009-03-11 |
EP2032139A4 true EP2032139A4 (en) | 2012-08-22 |
Family
ID=38834447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07784540A Withdrawn EP2032139A4 (en) | 2006-06-23 | 2007-06-25 | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2032139A4 (en) |
JP (1) | JP2009541360A (en) |
KR (1) | KR20090023729A (en) |
CN (1) | CN101484169A (en) |
AU (1) | AU2007260822B2 (en) |
CA (1) | CA2660650A1 (en) |
IL (1) | IL196066A0 (en) |
MX (1) | MX2008016115A (en) |
NO (1) | NO20090119L (en) |
WO (1) | WO2007150075A2 (en) |
ZA (1) | ZA200810098B (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040253310A1 (en) | 2001-09-21 | 2004-12-16 | Gina Fischer | Morphine polymer release system |
US20040234602A1 (en) | 2001-09-21 | 2004-11-25 | Gina Fischer | Polymer release system |
ATE495732T1 (en) | 2003-03-26 | 2011-02-15 | Egalet As | CONTROLLED RELEASE MORPHINE SYSTEM |
WO2008148798A2 (en) | 2007-06-04 | 2008-12-11 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
US20090311335A1 (en) * | 2008-06-12 | 2009-12-17 | Scott Jenkins | Combination of a triptan and an nsaid |
EP2393484A1 (en) | 2009-02-06 | 2011-12-14 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
BRPI1014275B8 (en) | 2009-04-24 | 2021-05-25 | Iceutica Pty Ltd | composition comprising indomethacin particles dispersed in at least two partially ground mill materials |
EP3167875A1 (en) * | 2009-05-27 | 2017-05-17 | Alkermes Pharma Ireland Limited | Reduction of flake-like aggregation in nanoparticulate meloxicam compositions |
CA2766179A1 (en) | 2009-06-24 | 2010-12-29 | Egalet Ltd. | Controlled release formulations |
PT2826467T (en) | 2010-12-22 | 2017-10-25 | Purdue Pharma Lp | Encased tamper resistant controlled release dosage forms |
CA2822769C (en) | 2010-12-23 | 2016-10-04 | Purdue Pharma L.P. | Tamper resistant solid oral dosage forms |
EP2586429A1 (en) * | 2011-10-26 | 2013-05-01 | Freund Pharmatec Ltd. | Multi-unit drug delivery device for pulsatile or sustained release |
CN103070906A (en) * | 2011-12-08 | 2013-05-01 | 赵联华 | Quality control method of injection composition for treating orthopedic diseases |
WO2013098591A1 (en) * | 2011-12-29 | 2013-07-04 | Laboratorios Andrómaco S.A. | Vaginal ring including meloxicam and an agent for modulating the release of the active principle, which can be used as a continuous-use contraceptive in women |
AU2013285988A1 (en) | 2012-07-06 | 2015-02-12 | Egalet Ltd. | Abuse deterrent pharmaceutical compositions for controlled release |
SG11201506064UA (en) | 2013-02-05 | 2015-08-28 | Purdue Pharma Lp | Tamper resistant pharmaceutical formulations |
US10751287B2 (en) | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
US9526734B2 (en) | 2014-06-09 | 2016-12-27 | Iceutica Pty Ltd. | Formulation of meloxicam |
US9132096B1 (en) | 2014-09-12 | 2015-09-15 | Alkermes Pharma Ireland Limited | Abuse resistant pharmaceutical compositions |
WO2021257784A1 (en) * | 2020-06-18 | 2021-12-23 | Verté Therapeutics, Llc | Injectable meloxicam formulations |
CN115025066B (en) * | 2021-05-25 | 2023-05-16 | 重庆市畜牧科学院 | Preparation method of traditional Chinese medicine slow-release particles with stable quality and capable of resisting diarrhea of piglets |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999013799A1 (en) * | 1997-09-17 | 1999-03-25 | Euro-Celtique, S.A. | Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor |
WO2001032148A1 (en) * | 1999-10-29 | 2001-05-10 | Euro-Celtique, S.A. | Controlled release hydrocodone formulations |
WO2003030872A2 (en) * | 2001-10-12 | 2003-04-17 | Elan Pharma International Ltd. | Compositions having a combination of particles for immediate release and for controlled release |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2311442A1 (en) * | 1998-11-02 | 2011-04-20 | Elan Pharma International Limited | Multiparticulate modified release composition |
US6716449B2 (en) * | 2000-02-08 | 2004-04-06 | Euro-Celtique S.A. | Controlled-release compositions containing opioid agonist and antagonist |
US8512727B2 (en) * | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
-
2007
- 2007-06-25 WO PCT/US2007/072054 patent/WO2007150075A2/en active Application Filing
- 2007-06-25 AU AU2007260822A patent/AU2007260822B2/en not_active Expired - Fee Related
- 2007-06-25 MX MX2008016115A patent/MX2008016115A/en not_active Application Discontinuation
- 2007-06-25 EP EP07784540A patent/EP2032139A4/en not_active Withdrawn
- 2007-06-25 CN CNA2007800235166A patent/CN101484169A/en active Pending
- 2007-06-25 KR KR1020097001440A patent/KR20090023729A/en not_active Application Discontinuation
- 2007-06-25 JP JP2009516757A patent/JP2009541360A/en active Pending
- 2007-06-25 CA CA002660650A patent/CA2660650A1/en not_active Abandoned
-
2008
- 2008-11-27 ZA ZA200810098A patent/ZA200810098B/en unknown
- 2008-12-18 IL IL196066A patent/IL196066A0/en unknown
-
2009
- 2009-01-09 NO NO20090119A patent/NO20090119L/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999013799A1 (en) * | 1997-09-17 | 1999-03-25 | Euro-Celtique, S.A. | Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor |
WO2001032148A1 (en) * | 1999-10-29 | 2001-05-10 | Euro-Celtique, S.A. | Controlled release hydrocodone formulations |
WO2003030872A2 (en) * | 2001-10-12 | 2003-04-17 | Elan Pharma International Ltd. | Compositions having a combination of particles for immediate release and for controlled release |
Also Published As
Publication number | Publication date |
---|---|
AU2007260822A1 (en) | 2007-12-27 |
EP2032139A2 (en) | 2009-03-11 |
WO2007150075A2 (en) | 2007-12-27 |
CA2660650A1 (en) | 2007-12-27 |
ZA200810098B (en) | 2009-12-30 |
KR20090023729A (en) | 2009-03-05 |
JP2009541360A (en) | 2009-11-26 |
CN101484169A (en) | 2009-07-15 |
NO20090119L (en) | 2009-03-20 |
MX2008016115A (en) | 2009-01-20 |
IL196066A0 (en) | 2009-09-01 |
WO2007150075A3 (en) | 2008-04-24 |
AU2007260822B2 (en) | 2012-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL196066A0 (en) | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone | |
SG138592A1 (en) | Nanoparticulate and controlled release compositions comprising cephalosporin | |
IL244442B (en) | Substituted acylanilide compounds and uses thereof | |
ZA200809971B (en) | Nanoparticulate posaconazole formulations | |
ZA200810221B (en) | Compositions comprising nanopaticulate naproxen and controlled release hydrocodone | |
IL199006A0 (en) | Nanoparticulate formulations and methods for the making and use thereof | |
EP2074142A4 (en) | Compounds for stimulating p-glycoprotein function and uses thereof | |
ZA200807397B (en) | Nanoparticulate carvedilol formulations | |
GB0621160D0 (en) | Compounds and uses thereof | |
EP2077863A4 (en) | Intrabodies | |
IL187431A0 (en) | Nanoparticulate and controlled release compositions comprising a cephalosporin | |
GB0611115D0 (en) | Compounds and their use | |
EP2124908A4 (en) | Compounds and uses thereof | |
HK1117060A1 (en) | Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds | |
EP1977992A4 (en) | Nanosemiconductor particle | |
TWI348269B (en) | Transceiver and compound fileter | |
EP2120563A4 (en) | Compounds and uses thereof | |
EP2069371A4 (en) | Organo-arsenoxide compounds and use thereof | |
ZA200701372B (en) | Loading device | |
TWI370812B (en) | Ester compound and its use | |
EP2016388A4 (en) | Particle monitor | |
GB0614871D0 (en) | Proximity activated camera | |
ZA200710715B (en) | Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds | |
IL197074A0 (en) | Thiadiazole compound and use thereof | |
EP2099459A4 (en) | Compounds and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20081223 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
DAX | Request for extension of the european patent (deleted) | ||
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: KLINE, LAURA Inventor name: PRUITT, JOHN Inventor name: RYDE, TUULA Inventor name: COOPER, EUGENE R. Inventor name: SINGH-REKHI, GURVINDER Inventor name: JENKINS, SCOTT Inventor name: LIVERSIDGE, GARY Inventor name: FANNING, NIALL Inventor name: DEVANE, JOHN Inventor name: STARK, PAUL |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20120723 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 9/50 20060101ALI20120717BHEP Ipc: A61K 9/14 20060101ALI20120717BHEP Ipc: A61K 9/51 20060101ALI20120717BHEP Ipc: A61K 31/485 20060101AFI20120717BHEP Ipc: B32B 25/00 20060101ALI20120717BHEP Ipc: A61K 9/54 20060101ALI20120717BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20130103 |